Coty investors face losses after alleged concealed deteriorating trends, according to Hagens Berman (12-day deadline alert)

Coty Inc. (NYSE: COTY) faces a securities class action lawsuit representing investors who purchased or otherwise acquired Coty common stock between November 5, 2025 and February 4, 2026. The lawsuit follows Coty’s February 5, 2026 Q2 2026 earnings report, which depicted serious operational issues and the abrupt departure of its CEO, Nabi. This news drove Coty’s shares down more than 8% on that day. Hagens Berman Sobol Shapiro LLP has said it will investigate claims that Coty violated federal securities laws and urges investors who suffered losses to submit them; witnesses who can assist may contact the firm. View our latest video summary of the allegations at youtu.be/jQoWASUHcgI. Class Period: Nov. 5, 2025 – Feb. 4, 2026. Lead Plaintiff Deadline: May 22, 2026. Visit www.hbsslaw.com/investor-fraud/coty. Contact the firm at COTY@hbsslaw.com or 844-916-0895. Coty is a global beauty company with brands in fragrance, color cosmetics, and skin and body care, operating through Prestige and Consumer Beauty segments. The lawsuit focuses on Coty’s disclosures about business trends within these segments. Specifically, on November 5, 2025, during the Q1 2026 results, Coty told investors that sales trends should improve in fiscal 2026, and Nabi stated that profitability and the balance sheet would strengthen, with fiscal 2026 trends improving in line with expectations. The company reaffirmed its FY 2026 EBITDA target of $1 billion. The complaint alleges false and misleading statements, with failure to disclose Consumer Beauty underperformance, margins compressed by higher marketing investments, and slowing Prestige fragrance growth. Investors learned the truth weeks after the Q1 report when Coty announced Nabi’s departure on December 12, 2025, sending the stock lower. On February 5, 2026, Coty reported Q2 2026 results showing Consumer Beauty’s operating income down over 70% year over year; Prestige’s operating income also fell over 18%. Coty withdrew its FY 2026 EBITDA and free cash flow guidance. During the earnings call, management projected mid-single-digit declines in like-for-like revenue for Q3, driven by declines in Consumer Beauty, and noted destocking headwinds and an intensified promotional environment as a headwind to net sales and gross margin. This news drove the price of Coty shares down over 8%. Hagens Berman is investigating whether Coty misled investors about its segment trends and whether year-over-year softness relates to earlier destocking issues, and is examining Nabi’s abrupt departure. If you invested in Coty with substantial losses or have information that could assist the investigation, submit losses. For more information, read more about the case and the investigation. Whistleblowers: Non-public information may be eligible for rewards under the SEC Whistleblower program; contact Reed Kathrein at 844-916-0895 or COTY@hbsslaw.com.